
News|Articles|October 28, 2024
Cell-based phenotypic screening with Incucyte® Live-Cell Analysis Systems
Author(s)Sartorius
Phenotypic screening is a vital tool in drug discovery, enabling scientists to rapidly identify potential drugs early in the discovery pipeline. Kinetic information gained by repeated image acquisition within a physiologically relevant environment provides insight into the dynamic changes which are often overlooked using end-point analysis alone.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Trending on BioPharm International
1
Industrial-Scale Cell Therapy Automation Gains Traction with New Cellares Funding
2
FDA Fast Tracks Innovent’s Trispecific Antibody for Multiple Myeloma
3
HHS Releases New Guidance on Lowering Prescription Drug Prices Through DTC Programs
4
AstraZeneca’s $15 Billion Investment Deepens China R&D and Manufacturing Footprint
5